{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-006599","form_type":"8-K","ticker":"BMRN","cik":"0001048477","company_name":"BIOMARIN PHARMACEUTICAL INC","filed_at":"2024-01-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.223225+00:00","generated_at":"2026-06-07T00:21:20.166650+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"BioMarin CCO Jeffrey Ajer to step down effective July 1, 2024","bullets":["Jeffrey Ajer, EVP and Chief Commercial Officer, will depart on July 1, 2024.","No successor named; compensation unchanged until departure date.","Separation treated as without-cause termination; Ajer eligible for severance per employment agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-006599","json":"https://secwatch.observer/filing/0001193125-24-006599.json","markdown":"https://secwatch.observer/filing/0001193125-24-006599.md","text":"https://secwatch.observer/filing/0001193125-24-006599.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1048477/000119312524006599/0001193125-24-006599-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1048477/000119312524006599/d719423d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T00:21:20.166650+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"18309dc77f","claim":"Jeffrey Ajer departed as Executive Vice President and Chief Commercial Officer at BIOMARIN PHARMACEUTICAL INC.","evidence_excerpt":"On January 11, 2024, BioMarin Pharmaceutical Inc. (“BioMarin” or the “Company”) announced that Mr. Jeffrey Ajer would step down as the Company’s Executive Vice President and Chief Commercial Officer, effective July 1, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1048477/000119312524006599/0001193125-24-006599-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"step down"},{"label":"Role","value":"Executive Vice President and Chief Commercial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}